Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Aflivu

Exceptional medication
  • Active ingredient(s):
    aflibercept
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Injectable Solution (syringe) 40 mg/mL (0.165 mL to 0.177 mL) DIN : 2554178
    • Injectable solution 40 mg/mL (0.278 mL) DIN : 2554194

Yesafili

Exceptional medication
  • Active ingredient(s):
    aflibercept
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Injectable Solution (syringe) 40 mg/mL (0.165 mL to 0.177 mL) DIN : 2558238
    • Injectable solution 40 mg/mL (0.278 mL) DIN : 2535858

Praluent

Exceptional medication
  • Active ingredient(s):
    alirocumab
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution (pen) 150 mg/mL (1 mL) DIN : 2453835
    • Subcutaneous Injectable Solution (pen) 75 mg/mL (1 mL) DIN : 2453819
    • Subcutaneous Injectable Solution (pen) 150 mg/mL (2 mL) DIN : 2547732

Truqap

Exceptional medication
  • Active ingredient(s):
    capivasertib
  • Manufactured by:
    AstraZeneca Canada Inc. (AZC)
  • Strength and dosage form:
    • Tablet 160 mg DIN : 2544733
    • Tablet 200 mg DIN : 2544741

Dupixent

Exceptional medication
  • Active ingredient(s):
    dupilumab
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 150 mg/mL (2 mL) DIN : 2470365
    • Subcutaneous Injectable Solution syringe 175 mg/mL (1,14 mL) DIN : 2492504
    • Subcutaneous Injectable Solution (pen) 150 mg/mL (2 mL) DIN : 2510049
    • Subcutaneous Injectable Solution (pen) 175 mg/mL (1,14 mL) DIN : 2524252

Pro-Edoxaban

Exceptional medication
  • Active ingredient(s):
    edoxaban
  • Manufactured by:
    Pro-Doc Ltée (Pro Doc)
  • Strength and dosage form:
    • Tablet 30 mg DIN : 2556960
    • Tablet 60 mg DIN : 2556979

Balversa

Exceptional medication
  • Active ingredient(s):
    erdafitinib
  • Manufactured by:
    Janssen Inc. (Janss. Inc)
  • Strength and dosage form:
    • Tablet 3 mg DIN : 2493217
    • Tablet 4 mg DIN : 2493225
    • Tablet 5 mg DIN : 2493233

Boost 2.24

Exceptional medication

Leqvio

Exceptional medication
  • Active ingredient(s):
    inclisiran
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 189 mg/mL (1,5 mL) DIN : 2518376

Tibsovo

Exceptional medication
  • Active ingredient(s):
    ivosidenib
  • Manufactured by:
    Servier Canada Inc. (Servier)
  • Strength and dosage form:
    Tablet 250 mg DIN : 2549980
Page 140 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.